Hallie Jackson NOW – Jan. 5 | NBC News NOW

President Trump talks to NBC News about the capture of deposed Venezuelan leader Nicolás Maduro, the CDC will now recommend fewer vaccines for children, and a GLP-1 pill is now available in the U.S. For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com » Subscribe to NBC […]

The Wegovy weight loss pill is now available in the U.S.

For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Subscribe to Here’s the Scoop podcast: https://www.nbcnews.com/heres-the-scoop-daily-podcast Every day, NBC News helps people understand what’s happening and why it matters — through fact-based reporting, meaningful conversations, and powerful stories. From its […]

GM may have found a simpler way to deliver a ‘premium car’ feel

General Motors’ stock just finished one of its best runs since the company exited bankruptcy. Now GM is talking about the kind of engineering that goes on behind the scenes and helps explain why investors are starting to like the story. The automaker just filed for a patent on a shock absorber that changes how […]

The Vegan Food Trends That Will Define 2026

As we head into a new year, one thing remains certain: the food landscape will continue to grow, adapt, and evolve. Experts predict expansion across several categories, from alcohol-free drinks and matcha-infused products to a boom in “swicy,” or sweet-and-spicy, flavors. Already, 2026 is shaping up to be a jam-packed year. Below, explore more of […]

Wegovy Now Available in Pill Version

A new stage in the boom of weight loss drugs began on Monday: Novo Nordisk rolled out a pill version of Wegovy nationwide, reports the Washington Post . The company is betting that a pill will expand the GLP-1 market to those leery of shots. Doctors can now prescribe the once-daily…

SGLT-2 inhibitors linked to lower risk of diabetic foot nerve damage

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared to those taking glucagon-like peptide-1 (GLP-1) receptor agonists.